WO2013026999A1 - Système de gestion de plaies - Google Patents
Système de gestion de plaies Download PDFInfo
- Publication number
- WO2013026999A1 WO2013026999A1 PCT/GB2012/000667 GB2012000667W WO2013026999A1 WO 2013026999 A1 WO2013026999 A1 WO 2013026999A1 GB 2012000667 W GB2012000667 W GB 2012000667W WO 2013026999 A1 WO2013026999 A1 WO 2013026999A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound
- management system
- wound management
- dressing
- sensors
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 238000005516 engineering process Methods 0.000 claims abstract description 17
- 230000036541 health Effects 0.000 claims abstract description 12
- 210000000416 exudates and transudate Anatomy 0.000 claims description 26
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 22
- 229910052802 copper Inorganic materials 0.000 claims description 22
- 239000010949 copper Substances 0.000 claims description 22
- 230000005540 biological transmission Effects 0.000 claims description 16
- 238000012546 transfer Methods 0.000 claims description 16
- 230000035876 healing Effects 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 10
- 238000005259 measurement Methods 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 229910001416 lithium ion Inorganic materials 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 150000002739 metals Chemical class 0.000 claims description 5
- 230000003287 optical effect Effects 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 230000036571 hydration Effects 0.000 claims description 4
- 238000006703 hydration reaction Methods 0.000 claims description 4
- 244000052769 pathogen Species 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 3
- OJIJEKBXJYRIBZ-UHFFFAOYSA-N cadmium nickel Chemical compound [Ni].[Cd] OJIJEKBXJYRIBZ-UHFFFAOYSA-N 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 230000031700 light absorption Effects 0.000 claims description 2
- 230000004962 physiological condition Effects 0.000 claims description 2
- 238000004171 remote diagnosis Methods 0.000 claims 1
- 230000000153 supplemental effect Effects 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 155
- 208000027418 Wounds and injury Diseases 0.000 abstract description 155
- 230000001684 chronic effect Effects 0.000 abstract description 11
- 238000003745 diagnosis Methods 0.000 abstract description 5
- 230000004044 response Effects 0.000 abstract description 5
- 230000001419 dependent effect Effects 0.000 abstract description 4
- 230000000638 stimulation Effects 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- 208000005230 Leg Ulcer Diseases 0.000 abstract description 3
- 230000001172 regenerating effect Effects 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 37
- 210000004027 cell Anatomy 0.000 description 21
- 238000007726 management method Methods 0.000 description 15
- 208000015181 infectious disease Diseases 0.000 description 13
- 230000001939 inductive effect Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000000919 ceramic Substances 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 8
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 238000012552 review Methods 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 238000005538 encapsulation Methods 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 230000035699 permeability Effects 0.000 description 6
- 238000007639 printing Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 230000000474 nursing effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000002411 adverse Effects 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- 206010048038 Wound infection Diseases 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- 206010056340 Diabetic ulcer Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000007647 flexography Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000006247 magnetic powder Substances 0.000 description 2
- 230000005415 magnetization Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000007650 screen-printing Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 description 1
- 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000012505 colouration Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000002508 contact lithography Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 239000012776 electronic material Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- -1 hydrogen cations Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000005442 molecular electronic Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0468—Specially adapted for promoting wound healing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/002—Monitoring the patient using a local or closed circuit, e.g. in a room or building
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6828—Leg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient; User input means
- A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
Definitions
- the present invention relates to a system, apparatus and method for management of wounds.
- the present invention relates to a system for diagnosis and apparatus to assist in wound treatment which is particularly applicable to treatment of leg ulcers.
- Chronic wounds almost without exception contain bacterial flora. These bacteria may be indigenous to the patient or might be exogenous to the wound. Closure of a wound is effectively possible by control of the level of this bacterial flora. Just because there is bacteria and foreign matter present within a wound, does not give rise to an infection; no negative impact may be realised. Accordingly wound control is not determined by control of the presence of bacteria, other organisms and foreign bodies at a wound site. The provision of wound information enables a tailored response by a physician whereby to enable wound repair to be facilitated; any treatment can be treated topically as opposed to having to use systemic antibiotics. This would also lead to less clinical intervention/hospitalisation (e.g. due to sepsis) and would reduce the use of antibiotics and other complications of infection.
- Modern dressings usually use synthetic polymers and range in complexity depending on application. Ordinary dressings are passive constructs such as gauze that simply cover the wound. Interactive materials contain polymeric films and foams which have properties suitable for shallow wounds with low exudates, permitting wound checking. Finally bioactive wound dressings are produced using materials such as hydrocolloids, alginates and collagens with state of the art dressings incorporating active ingredients such as antimicrobials and growth factors. It is known that the maintenance of a moist wound environment promotes the healing of wounds, especially burns and chronic wounds such as ulcers. However, it is also desirable to avoid excessive moisture or pooling of wound exudate on the wound, since liquid exudate causes maceration of skin adjacent to . the wound and other difficulties. Furthermore, liquid exudate can leak from the wound site and contaminate clothes or bedding.
- US 2006111657 provides a wound treatment device comprising a water- impermeable envelope having at least one aperture, wherein the envelope contains a therapeutic substance, and the aperture in the envelope is blocked by a material that breaks down in the presence of one or more active components of wound fluid thereby permitting the therapeutic substance to contact the wound fluid.
- GB2408330 provides a wound dressing wherein the pH of a wound may be assessed using a film preferably of hydrogel which changes colour in dependence upon pH. Wound pH information may be used to facilitate selection of the appropriate treatment to which the wound should be subjected.
- the hydrogel film is incorporated into a dressing.
- the present invention seeks to provide an improved wound dressing which seeks to provide feedback data relating to healing progress of the wound.
- a wound management system incorporating one or more sensors relating to measurement of a physiological condition, the system comprising a sensor array printed on a flexible substrate to monitor the healing process by means of measurement of at least two or more parameters such as temperature, moisture, impedance, Ph, levels of particular compounds or gases, light absorption or light transmission, the sensors being arranged in at least a two dimensional triangulation arrangement whereby to assist in clinical decisions.
- the present invention accordingly enables control of a wound infection to be more simply managed by the review of certain key indicators associated with wound exudate components that are present at a wound site.
- the sensors are arranged to provide an informatics capability relative to wound progress, the informatics capability enabling data to be transmitted, to a remote device.
- the sensors could provide data to processor circuitry which can process the data for storage or transmission or for storage and subsequent transmission via wi-fi data transfer protocols.
- processor circuitry can process the data for storage or transmission or for storage and subsequent transmission via wi-fi data transfer protocols.
- a history / library of wound conditions using different demographics e.g. gender, age, condition and dressing type can be generated. This will in turn have a major influence ensuring that the right treatment is given at an early stage to prevent the misuse of drugs, thereby playing a major role in reducing the drugs bill.
- Other major cost saving will be accrued in saving nursing time, as they will be able to prioritise home visits, and make major savings on travelling costs, both which take up the majority of costs for district and community nursing. It will also have an impact in reducing our carbon footprint.
- the wound management system could include a sensor array printed on a flexible substrate such as a flexible printed circuit to enable at least some of the functionality of the dressing, by way of provision of transmission path, capacitance or impedance.
- a micro sensor camera array may be present, whereby to enable images to be transferred from the wound.
- Nano-fibres, provided with a conductive coating may be used in the construction of the dressing system to enable an electric current to be passed about the wound.
- the wound management system can comprise a rechargeable electrical cell or battery.
- the rechargeable electrical cell or battery is a one of a cadmium-nickel, lithium-ion or lithium-polymer cell or battery. Even more preferably the electrical cell or battery is plastically deformable.
- Figures 4 & 4a shows an arrangement of components upon two layers of a wound system as shown in Figure 1;
- FIG 1 is an exploded view of a wound treatment system according to an embodiment of the present invention.
- the system includes a wound containment and exudate absorbing layer (A), an encapsulation layer (B), a sensor support layer (C), an encapsulation/strike through barrier (D) and an electromagnetic element support layer (E).
- the electromagnetic element as illustrated in Figure 2 preferably comprises a planar spiral copper coil on a polymeric substrate and a high- permeability magnetic layer (equivalent to the core of a conventional electromagnet) in the form of a ceramic/polymer composite; an electrical cell, such as a lithium ion-ion electrical cell (often referred to as a battery) can be placed between the encapsulation barrier and encapsulation layer.
- the copper spiral may be fabricated by Focussed Field Deposition (FFD) onto a flexible polyamide substrate.
- FFD Focussed Field Deposition
- the ceramic/polymer composite is deposited on both sides of the substrate by stencil and screen printing, above and below the copper spiral coil, with respect to layer E.
- FFD technology which is a non-immersion additive electroplating process, was primarily designed to produce flexible circuitry using electro deposited copper extracted from copper sulphate solutions. Because copper is deposited on the substrate only where necessary and only in the amount needed, the process will significantly lower production costs compared with prior similar technologies.
- the advantages of using FFD for the copper spiral coil are that it: - is a non-immersion process - allows multiple substrate choice - uses independent circuit patterns with no connections or robber bars means no waste - has a totally controlled thicknesses capability across thickness profile.
- the mass fraction of the ceramic in the ceramic/polymer composite must be greater than the mass fractions of fillers typically incorporated into polymer-matrix thick films.
- such a high mass fraction of filler can adversely affect adhesion and can make the film susceptible to mechanical failure and delamination during flexure.
- flexible lithium ion batteries such as the flexible lithium polymer electrical cells as produced by Solicore, Inc., marketed under their "Flexion" trade name.
- Such lithium cells are available in a variety of shapes and sizes.
- 3V at 10mA can be provided in a package dimensioned at less than 26 x 29 x 0.45mm.
- a recharging mechanism can be created in combination with the exudates. Since an exudate is an electrolyte, a galvanic cell can be created, by the use of metal terminals in contact with exudate. Suitable metals have been determined to be copper and zinc; a 1.1V potential difference can be obtained across a sulphate salt bridge, the zinc becomes oxidized and passes into solution and the copper-ion solution is reduced. Zinc metal becomes oxidised to zinc oxide and the copper is reduced. A simple overview of a zinc-copper electrochemical cell is shown in Figure 3.
- the mass fraction of the ceramic in the ceramic/polymer composite must be greater than the mass fractions of fillers typically incorporated into polymer-matrix thick films.
- such a high mass fraction of filler can adversely affect adhesion and can make the film susceptible to mechanical failure and delamination during flexure.
- Layer C as well as being an encapsulation layer can also act to support sensors, in which case, electrical connections as present between layers El and D may also be required.
- a sensor array fixed into layer C could assist in the monitoring of wound progression or regression through the measurement of cell impedance, pH value and Nitric Oxide levels. It will be appreciated that sensors relating to specific conditions may benefit from being supported on a particular layer; indeed it is necessary for certain indications to be measured within the exudate, for example.
- the particular order of layers may change; specific layers may not be required, such as the indicative membrane layer and the particular layers will be dependent upon the need of a wound to be dressed, as will be readily appreciated by healthcare professionals.
- the delivery will require the patterning of sensor arrays to gather information at discrete points over the wound area. This will be developed through printing technology and acquisition of data from these will be achieved through a wireless communication. Data processing and display will be required to provide a tool to diagnose wound state and this will include progression through capture of longitudinal data. Remote monitoring will require data transmission through appropriate telecommunications, with emphasis on security and patient sensitive information. Healing enhancement will be delivered through electromagnetic stimulation. Power will be required to achieve this and the aim will be to deliver this through power scavenging or rechargeable battery technology.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Radiology & Medical Imaging (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Computer Networks & Wireless Communication (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
La présente invention concerne un système, un appareil et un procédé de gestion de plaies. En particulier, la présente invention concerne, de façon non limitative, un système de diagnostic et un appareil d'assistance pour le traitement de plaies, dont l'utilisation est en particulier indiquée pour le traitement d'ulcères de la jambe. La présente invention vise également à proposer un système de pansement intelligent qui permettra une gestion améliorée du soin de plaies chroniques à la fois du point de vue du patient et d'un point de vue économique. Le remplacement du pansement, soit dans une clinique, soit dans un lieu situé à distance devrait être réalisé en fonction de l'état de la plaie tel que déterminé par l'intermédiaire d'un diagnostic fondé sur des preuves. Un système de pansement selon la présente invention permettra la collecte d'informations sur l'état de la plaie par l'intermédiaire de technologies de détection incorporées (température, pH, humidité et impédance cellulaire) qui répondent à des stimuli physiques. Les signaux résultants seront transmis et peuvent être surveillés dans un environnement clinique ou dans un lieu de résidence, soit par le patient, soit à distance par le professionnel de santé à l'aide d'une technologie de télécommunication. Le pansement administrera également une thérapie régénérative par l'intermédiaire d'une application appropriée d'une stimulation électromagnétique en réponse à l'état de la plaie.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1114352.6 | 2011-08-19 | ||
| GBGB1114352.6A GB201114352D0 (en) | 2011-08-19 | 2011-08-19 | System,apparatus and method for management of wounds |
| GBGB1206918.3A GB201206918D0 (en) | 2012-04-19 | 2012-04-19 | A wound management system |
| GB1206918.3 | 2012-04-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2013026999A1 true WO2013026999A1 (fr) | 2013-02-28 |
Family
ID=47071407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2012/000667 WO2013026999A1 (fr) | 2011-08-19 | 2012-08-20 | Système de gestion de plaies |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2013026999A1 (fr) |
Cited By (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3034054A1 (fr) * | 2014-12-16 | 2016-06-22 | Absorbest AB | Pansement pourvu d'un capteur et son procédé de fabrication |
| WO2016166731A1 (fr) * | 2015-04-15 | 2016-10-20 | King Abdullah University Of Science And Technology | Pansement comprenant des éléments électroniques réutilisables pour surveillance sans fil |
| WO2017015208A1 (fr) * | 2015-07-17 | 2017-01-26 | Hollister Incorporated | Pansement et méthode de traitement de plaies aiguës et chroniques |
| CN108371584A (zh) * | 2018-02-07 | 2018-08-07 | 苏州元禾医疗器械有限公司 | 一种智能敷料 |
| CN108498078A (zh) * | 2018-04-24 | 2018-09-07 | 张新平 | 物联组网的评估指挥系统 |
| WO2019048638A1 (fr) * | 2017-09-10 | 2019-03-14 | Smith & Nephew Plc | Pansements de thérapie de plaie activés par capteur et systèmes mettant en œuvre une cybersécurité |
| US10288590B2 (en) | 2013-10-08 | 2019-05-14 | Smith & Nephew Plc | PH indicator device and formulation |
| WO2019063488A3 (fr) * | 2017-09-26 | 2019-05-16 | Smith & Nephew Plc | Positionnement de capteur et détection optique pour pansements et systèmes de traitement de plaie activés par capteur |
| US10610624B2 (en) | 2013-03-14 | 2020-04-07 | Smith & Nephew, Inc. | Reduced pressure therapy blockage detection |
| US10639502B2 (en) | 2010-10-12 | 2020-05-05 | Smith & Nephew, Inc. | Medical device |
| US10991185B1 (en) | 2020-07-20 | 2021-04-27 | Abbott Laboratories | Digital pass verification systems and methods |
| CN112890805A (zh) * | 2021-01-14 | 2021-06-04 | 四川大学华西医院 | 一种自动寻找伤口并识别伤口状态的仪器 |
| US11076997B2 (en) | 2017-07-25 | 2021-08-03 | Smith & Nephew Plc | Restriction of sensor-monitored region for sensor-enabled wound dressings |
| US11315681B2 (en) | 2015-10-07 | 2022-04-26 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
| US11324424B2 (en) | 2017-03-09 | 2022-05-10 | Smith & Nephew Plc | Apparatus and method for imaging blood in a target region of tissue |
| US11369730B2 (en) | 2016-09-29 | 2022-06-28 | Smith & Nephew, Inc. | Construction and protection of components in negative pressure wound therapy systems |
| US11559438B2 (en) | 2017-11-15 | 2023-01-24 | Smith & Nephew Plc | Integrated sensor enabled wound monitoring and/or therapy dressings and systems |
| CN115645149A (zh) * | 2022-12-14 | 2023-01-31 | 宁夏医科大学总医院 | 一种用于慢性伤口的智能敷料系统 |
| US11596553B2 (en) | 2017-09-27 | 2023-03-07 | Smith & Nephew Plc | Ph sensing for sensor enabled negative pressure wound monitoring and therapy apparatuses |
| US11602461B2 (en) | 2016-05-13 | 2023-03-14 | Smith & Nephew, Inc. | Automatic wound coupling detection in negative pressure wound therapy systems |
| US11633153B2 (en) | 2017-06-23 | 2023-04-25 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
| US11638664B2 (en) | 2017-07-25 | 2023-05-02 | Smith & Nephew Plc | Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings |
| US11690570B2 (en) | 2017-03-09 | 2023-07-04 | Smith & Nephew Plc | Wound dressing, patch member and method of sensing one or more wound parameters |
| US11712508B2 (en) | 2017-07-10 | 2023-08-01 | Smith & Nephew, Inc. | Systems and methods for directly interacting with communications module of wound therapy apparatus |
| US11717447B2 (en) | 2016-05-13 | 2023-08-08 | Smith & Nephew Plc | Sensor enabled wound monitoring and therapy apparatus |
| US11759144B2 (en) | 2017-09-10 | 2023-09-19 | Smith & Nephew Plc | Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings |
| US11791030B2 (en) | 2017-05-15 | 2023-10-17 | Smith & Nephew Plc | Wound analysis device and method |
| US11793924B2 (en) | 2018-12-19 | 2023-10-24 | T.J.Smith And Nephew, Limited | Systems and methods for delivering prescribed wound therapy |
| US11839464B2 (en) | 2017-09-28 | 2023-12-12 | Smith & Nephew, Plc | Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus |
| US11883262B2 (en) | 2017-04-11 | 2024-01-30 | Smith & Nephew Plc | Component positioning and stress relief for sensor enabled wound dressings |
| US11925735B2 (en) | 2017-08-10 | 2024-03-12 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
| US11931165B2 (en) | 2017-09-10 | 2024-03-19 | Smith & Nephew Plc | Electrostatic discharge protection for sensors in wound therapy |
| US11944418B2 (en) | 2018-09-12 | 2024-04-02 | Smith & Nephew Plc | Device, apparatus and method of determining skin perfusion pressure |
| US11969538B2 (en) | 2018-12-21 | 2024-04-30 | T.J.Smith And Nephew, Limited | Wound therapy systems and methods with multiple power sources |
| US11974903B2 (en) | 2017-03-07 | 2024-05-07 | Smith & Nephew, Inc. | Reduced pressure therapy systems and methods including an antenna |
| US12002566B2 (en) | 2013-03-14 | 2024-06-04 | Smith & Nephew, Inc. | Attachment system for mounting apparatus |
| US12011942B2 (en) | 2019-03-18 | 2024-06-18 | Smith & Nephew Plc | Rules for sensor integrated substrates |
| US12016994B2 (en) | 2019-10-07 | 2024-06-25 | Smith & Nephew Plc | Sensor enabled negative pressure wound monitoring apparatus with different impedances inks |
| US12033738B2 (en) | 2017-05-15 | 2024-07-09 | Smith & Nephew Plc | Negative pressure wound therapy system using eulerian video magnification |
| US12090264B2 (en) | 2012-05-22 | 2024-09-17 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
| US12133789B2 (en) | 2014-07-31 | 2024-11-05 | Smith & Nephew, Inc. | Reduced pressure therapy apparatus construction and control |
| CN118986280A (zh) * | 2024-08-09 | 2024-11-22 | 苏州长润昱华医疗科技有限公司 | 一种基于石墨烯传感器的伤口感染监测预警系统 |
| US12178597B2 (en) | 2017-03-09 | 2024-12-31 | Smith & Nephew Plc | Device, apparatus and method of determining skin perfusion pressure |
| US12186164B2 (en) | 2018-10-16 | 2025-01-07 | Smith & Nephew Plc | Systems and method for applying biocompatible encapsulation to sensor enabled wound monitoring and therapy dressings |
| US12186165B2 (en) | 2018-09-28 | 2025-01-07 | T.J.Smith And Nephew, Limited | Optical fibers for optically sensing through wound dressings |
| US12263294B2 (en) | 2016-09-28 | 2025-04-01 | T.J.Smith And Nephew, Limited | Systems and methods for operating negative pressure wound therapy devices |
| US12299772B2 (en) | 2020-04-21 | 2025-05-13 | T.J.Smith And Nephew, Limited | Wound treatment management using augmented reality overlay |
| WO2025099485A1 (fr) * | 2023-11-10 | 2025-05-15 | Linxens Holding | Structure de circuit flexible et agencement de port intelligent doté d'une telle structure de circuit flexible |
| WO2025099493A1 (fr) * | 2023-11-10 | 2025-05-15 | Linxens Holding | Structure de circuit flexible et agencement à porter intelligent doté d'une telle structure de circuit flexible |
| US12370300B2 (en) | 2019-08-15 | 2025-07-29 | T.J.Smith And Nephew, Limited | Systems and methods for monitoring essential performance of wound therapy |
| US12409071B2 (en) | 2018-08-29 | 2025-09-09 | Smith & Nephew Plc | Component positioning and encapsulation for sensor enabled wound dressings |
Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0122085A1 (fr) | 1983-04-06 | 1984-10-17 | Smith and Nephew Associated Companies p.l.c. | Pansement |
| EP0123465A2 (fr) | 1983-04-13 | 1984-10-31 | SMITH & NEPHEW plc | Pansement chirurgical adhésif |
| EP0599589A1 (fr) | 1992-11-23 | 1994-06-01 | JOHNSON & JOHNSON MEDICAL, INC. | Pansement |
| EP0875222A1 (fr) | 1997-05-02 | 1998-11-04 | JOHNSON & JOHNSON MEDICAL, INC. | Pansements absorbants pour plaies |
| WO2004086043A1 (fr) | 2003-03-26 | 2004-10-07 | Johnson & Johnson Medical Limited | Prediction et detection d'une infection de plaie |
| GB2408330A (en) | 2003-11-22 | 2005-05-25 | Advanced Gel Technology Ltd | Polymeric materials for assessing pH |
| US20060111657A1 (en) | 2002-09-27 | 2006-05-25 | Deborah Addison | Wound treatment device |
| US20060253078A1 (en) * | 2005-04-25 | 2006-11-09 | Wu Jeffrey M | Method of treating skin disorders with stratum corneum piercing device |
| US20090149797A1 (en) * | 2007-12-05 | 2009-06-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System for reversible chemical modulation of neural activity |
| US20090204100A1 (en) * | 2006-06-12 | 2009-08-13 | Koninklijke Phillips Electronics N.V. | Body cover and a method of communicating a variation in temperature of the skin |
| GB2457470A (en) * | 2008-02-13 | 2009-08-19 | Pulse Medical Technologies Ltd | Silver ion wound dressing with electromagnetic coil |
| WO2009122188A2 (fr) | 2008-04-04 | 2009-10-08 | Axis-Shield Diagnostics Ltd | Procédé de contrôle d'infection de plaie |
| WO2009144615A1 (fr) * | 2008-05-26 | 2009-12-03 | Koninklijke Philips Electronics N.V. | Contrôle d'humidité d’un timbre à multiples électrodes pour surveillance et stimulation électrique de cicatrisation d'une plaie |
| US20100100160A1 (en) * | 2008-10-16 | 2010-04-22 | Philometron, Inc. | Methods and devices for self adjusting phototherapeutic intervention |
| US20110015591A1 (en) | 2009-07-14 | 2011-01-20 | Southwest Research Institute | Wound Healing Sensor Techniques |
-
2012
- 2012-08-20 WO PCT/GB2012/000667 patent/WO2013026999A1/fr active Application Filing
Patent Citations (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0122085A1 (fr) | 1983-04-06 | 1984-10-17 | Smith and Nephew Associated Companies p.l.c. | Pansement |
| EP0123465A2 (fr) | 1983-04-13 | 1984-10-31 | SMITH & NEPHEW plc | Pansement chirurgical adhésif |
| EP0599589A1 (fr) | 1992-11-23 | 1994-06-01 | JOHNSON & JOHNSON MEDICAL, INC. | Pansement |
| EP0875222A1 (fr) | 1997-05-02 | 1998-11-04 | JOHNSON & JOHNSON MEDICAL, INC. | Pansements absorbants pour plaies |
| US20060111657A1 (en) | 2002-09-27 | 2006-05-25 | Deborah Addison | Wound treatment device |
| WO2004086043A1 (fr) | 2003-03-26 | 2004-10-07 | Johnson & Johnson Medical Limited | Prediction et detection d'une infection de plaie |
| GB2408330A (en) | 2003-11-22 | 2005-05-25 | Advanced Gel Technology Ltd | Polymeric materials for assessing pH |
| US20060253078A1 (en) * | 2005-04-25 | 2006-11-09 | Wu Jeffrey M | Method of treating skin disorders with stratum corneum piercing device |
| US20090204100A1 (en) * | 2006-06-12 | 2009-08-13 | Koninklijke Phillips Electronics N.V. | Body cover and a method of communicating a variation in temperature of the skin |
| US20090149797A1 (en) * | 2007-12-05 | 2009-06-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System for reversible chemical modulation of neural activity |
| GB2457470A (en) * | 2008-02-13 | 2009-08-19 | Pulse Medical Technologies Ltd | Silver ion wound dressing with electromagnetic coil |
| WO2009122188A2 (fr) | 2008-04-04 | 2009-10-08 | Axis-Shield Diagnostics Ltd | Procédé de contrôle d'infection de plaie |
| WO2009144615A1 (fr) * | 2008-05-26 | 2009-12-03 | Koninklijke Philips Electronics N.V. | Contrôle d'humidité d’un timbre à multiples électrodes pour surveillance et stimulation électrique de cicatrisation d'une plaie |
| US20100100160A1 (en) * | 2008-10-16 | 2010-04-22 | Philometron, Inc. | Methods and devices for self adjusting phototherapeutic intervention |
| US20110015591A1 (en) | 2009-07-14 | 2011-01-20 | Southwest Research Institute | Wound Healing Sensor Techniques |
Cited By (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12403331B2 (en) | 2010-10-12 | 2025-09-02 | Smith & Nephew, Inc. | Medical device |
| US11565134B2 (en) | 2010-10-12 | 2023-01-31 | Smith & Nephew, Inc. | Medical device |
| US10639502B2 (en) | 2010-10-12 | 2020-05-05 | Smith & Nephew, Inc. | Medical device |
| US12090264B2 (en) | 2012-05-22 | 2024-09-17 | Smith & Nephew Plc | Apparatuses and methods for wound therapy |
| US10610624B2 (en) | 2013-03-14 | 2020-04-07 | Smith & Nephew, Inc. | Reduced pressure therapy blockage detection |
| US11633533B2 (en) | 2013-03-14 | 2023-04-25 | Smith & Nephew, Inc. | Control architecture for reduced pressure wound therapy apparatus |
| US12002566B2 (en) | 2013-03-14 | 2024-06-04 | Smith & Nephew, Inc. | Attachment system for mounting apparatus |
| US10905806B2 (en) | 2013-03-14 | 2021-02-02 | Smith & Nephew, Inc. | Reduced pressure wound therapy control and data communication |
| US10288590B2 (en) | 2013-10-08 | 2019-05-14 | Smith & Nephew Plc | PH indicator device and formulation |
| US12133789B2 (en) | 2014-07-31 | 2024-11-05 | Smith & Nephew, Inc. | Reduced pressure therapy apparatus construction and control |
| US10687984B2 (en) | 2014-12-16 | 2020-06-23 | Absorbest Ab | Wound dressing with a sensor |
| EP3034054A1 (fr) * | 2014-12-16 | 2016-06-22 | Absorbest AB | Pansement pourvu d'un capteur et son procédé de fabrication |
| WO2016166731A1 (fr) * | 2015-04-15 | 2016-10-20 | King Abdullah University Of Science And Technology | Pansement comprenant des éléments électroniques réutilisables pour surveillance sans fil |
| US10702153B2 (en) | 2015-04-15 | 2020-07-07 | King Abdullah University Of Science And Technology | Wound dressing with reusable electronics for wireless monitoring |
| WO2017015208A1 (fr) * | 2015-07-17 | 2017-01-26 | Hollister Incorporated | Pansement et méthode de traitement de plaies aiguës et chroniques |
| US11783943B2 (en) | 2015-10-07 | 2023-10-10 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
| US11315681B2 (en) | 2015-10-07 | 2022-04-26 | Smith & Nephew, Inc. | Reduced pressure therapy device operation and authorization monitoring |
| US11602461B2 (en) | 2016-05-13 | 2023-03-14 | Smith & Nephew, Inc. | Automatic wound coupling detection in negative pressure wound therapy systems |
| US11717447B2 (en) | 2016-05-13 | 2023-08-08 | Smith & Nephew Plc | Sensor enabled wound monitoring and therapy apparatus |
| US12263294B2 (en) | 2016-09-28 | 2025-04-01 | T.J.Smith And Nephew, Limited | Systems and methods for operating negative pressure wound therapy devices |
| US11369730B2 (en) | 2016-09-29 | 2022-06-28 | Smith & Nephew, Inc. | Construction and protection of components in negative pressure wound therapy systems |
| US12420006B2 (en) | 2016-09-29 | 2025-09-23 | Smith & Nephew, Inc. | Construction and protection of components in negative pressure wound therapy systems |
| US11974903B2 (en) | 2017-03-07 | 2024-05-07 | Smith & Nephew, Inc. | Reduced pressure therapy systems and methods including an antenna |
| US11324424B2 (en) | 2017-03-09 | 2022-05-10 | Smith & Nephew Plc | Apparatus and method for imaging blood in a target region of tissue |
| US12178597B2 (en) | 2017-03-09 | 2024-12-31 | Smith & Nephew Plc | Device, apparatus and method of determining skin perfusion pressure |
| US11690570B2 (en) | 2017-03-09 | 2023-07-04 | Smith & Nephew Plc | Wound dressing, patch member and method of sensing one or more wound parameters |
| US12245920B2 (en) | 2017-04-11 | 2025-03-11 | Smith & Nephew Plc | Component positioning and stress relief for sensor enabled wound dressings |
| US11883262B2 (en) | 2017-04-11 | 2024-01-30 | Smith & Nephew Plc | Component positioning and stress relief for sensor enabled wound dressings |
| US12033738B2 (en) | 2017-05-15 | 2024-07-09 | Smith & Nephew Plc | Negative pressure wound therapy system using eulerian video magnification |
| US12424307B2 (en) | 2017-05-15 | 2025-09-23 | Smith & Nephew Plc | Wound analysis device and method |
| US11791030B2 (en) | 2017-05-15 | 2023-10-17 | Smith & Nephew Plc | Wound analysis device and method |
| US11633153B2 (en) | 2017-06-23 | 2023-04-25 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
| US12102447B2 (en) | 2017-06-23 | 2024-10-01 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
| US12083262B2 (en) | 2017-07-10 | 2024-09-10 | Smith & Nephew, Inc. | Systems and methods for directly interacting with communications module of wound therapy apparatus |
| US11712508B2 (en) | 2017-07-10 | 2023-08-01 | Smith & Nephew, Inc. | Systems and methods for directly interacting with communications module of wound therapy apparatus |
| US11638664B2 (en) | 2017-07-25 | 2023-05-02 | Smith & Nephew Plc | Biocompatible encapsulation and component stress relief for sensor enabled negative pressure wound therapy dressings |
| US11076997B2 (en) | 2017-07-25 | 2021-08-03 | Smith & Nephew Plc | Restriction of sensor-monitored region for sensor-enabled wound dressings |
| US11925735B2 (en) | 2017-08-10 | 2024-03-12 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
| US12214111B2 (en) | 2017-08-10 | 2025-02-04 | Smith & Nephew Plc | Positioning of sensors for sensor enabled wound monitoring or therapy |
| US11759144B2 (en) | 2017-09-10 | 2023-09-19 | Smith & Nephew Plc | Systems and methods for inspection of encapsulation and components in sensor equipped wound dressings |
| US11633147B2 (en) | 2017-09-10 | 2023-04-25 | Smith & Nephew Plc | Sensor enabled wound therapy dressings and systems implementing cybersecurity |
| WO2019048638A1 (fr) * | 2017-09-10 | 2019-03-14 | Smith & Nephew Plc | Pansements de thérapie de plaie activés par capteur et systèmes mettant en œuvre une cybersécurité |
| CN111065362A (zh) * | 2017-09-10 | 2020-04-24 | 史密夫及内修公开有限公司 | 实施传感器的伤口治疗敷料和实施网络安全的系统 |
| US12114994B2 (en) | 2017-09-10 | 2024-10-15 | Smith & Nephew Plc | Sensor enabled wound therapy dressings and systems implementing cybersecurity |
| US11931165B2 (en) | 2017-09-10 | 2024-03-19 | Smith & Nephew Plc | Electrostatic discharge protection for sensors in wound therapy |
| CN111065362B (zh) * | 2017-09-10 | 2022-04-12 | 史密夫及内修公开有限公司 | 实施传感器的伤口治疗敷料和实施网络安全的系统 |
| US11957545B2 (en) | 2017-09-26 | 2024-04-16 | Smith & Nephew Plc | Sensor positioning and optical sensing for sensor enabled wound therapy dressings and systems |
| JP7354098B2 (ja) | 2017-09-26 | 2023-10-02 | スミス アンド ネフュー ピーエルシー | センサ対応型創傷療法被覆材およびシステムのためのセンサ位置決めおよび光学検知 |
| WO2019063488A3 (fr) * | 2017-09-26 | 2019-05-16 | Smith & Nephew Plc | Positionnement de capteur et détection optique pour pansements et systèmes de traitement de plaie activés par capteur |
| CN111107814A (zh) * | 2017-09-26 | 2020-05-05 | 史密夫及内修公开有限公司 | 用于实施传感器的伤口治疗敷料和系统的传感器定位和光学感测 |
| JP2020536599A (ja) * | 2017-09-26 | 2020-12-17 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | センサ対応型創傷療法被覆材およびシステムのためのセンサ位置決めおよび光学検知 |
| AU2018340324B2 (en) * | 2017-09-26 | 2024-08-08 | Smith & Nephew Plc | Sensor positioning and optical sensing for sensor enabled wound therapy dressings and systems |
| US12097092B2 (en) | 2017-09-27 | 2024-09-24 | Smith & Nephew Plc | pH sensing for sensor enabled negative pressure wound monitoring and therapy apparatuses |
| US11596553B2 (en) | 2017-09-27 | 2023-03-07 | Smith & Nephew Plc | Ph sensing for sensor enabled negative pressure wound monitoring and therapy apparatuses |
| US11839464B2 (en) | 2017-09-28 | 2023-12-12 | Smith & Nephew, Plc | Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus |
| US12290352B2 (en) | 2017-09-28 | 2025-05-06 | Smith & Nephew Plc | Neurostimulation and monitoring using sensor enabled wound monitoring and therapy apparatus |
| US11559438B2 (en) | 2017-11-15 | 2023-01-24 | Smith & Nephew Plc | Integrated sensor enabled wound monitoring and/or therapy dressings and systems |
| CN108371584A (zh) * | 2018-02-07 | 2018-08-07 | 苏州元禾医疗器械有限公司 | 一种智能敷料 |
| CN108498078A (zh) * | 2018-04-24 | 2018-09-07 | 张新平 | 物联组网的评估指挥系统 |
| WO2019205967A1 (fr) * | 2018-04-24 | 2019-10-31 | 上海锦辰医药科技有限公司 | Système d'évaluation et de commande reposant sur l'internet des objets |
| US12409071B2 (en) | 2018-08-29 | 2025-09-09 | Smith & Nephew Plc | Component positioning and encapsulation for sensor enabled wound dressings |
| US11944418B2 (en) | 2018-09-12 | 2024-04-02 | Smith & Nephew Plc | Device, apparatus and method of determining skin perfusion pressure |
| US12186165B2 (en) | 2018-09-28 | 2025-01-07 | T.J.Smith And Nephew, Limited | Optical fibers for optically sensing through wound dressings |
| US12186164B2 (en) | 2018-10-16 | 2025-01-07 | Smith & Nephew Plc | Systems and method for applying biocompatible encapsulation to sensor enabled wound monitoring and therapy dressings |
| US12268806B2 (en) | 2018-12-19 | 2025-04-08 | T.J.Smith And Nephew, Limited | Systems and methods for delivering prescribed wound therapy |
| US11793924B2 (en) | 2018-12-19 | 2023-10-24 | T.J.Smith And Nephew, Limited | Systems and methods for delivering prescribed wound therapy |
| US12226565B2 (en) | 2018-12-21 | 2025-02-18 | T.J.Smith And Nephew, Limited | Wound therapy systems and methods with multiple power sources |
| US11969538B2 (en) | 2018-12-21 | 2024-04-30 | T.J.Smith And Nephew, Limited | Wound therapy systems and methods with multiple power sources |
| US12011942B2 (en) | 2019-03-18 | 2024-06-18 | Smith & Nephew Plc | Rules for sensor integrated substrates |
| US12370300B2 (en) | 2019-08-15 | 2025-07-29 | T.J.Smith And Nephew, Limited | Systems and methods for monitoring essential performance of wound therapy |
| US12016994B2 (en) | 2019-10-07 | 2024-06-25 | Smith & Nephew Plc | Sensor enabled negative pressure wound monitoring apparatus with different impedances inks |
| US12299772B2 (en) | 2020-04-21 | 2025-05-13 | T.J.Smith And Nephew, Limited | Wound treatment management using augmented reality overlay |
| US11514738B2 (en) | 2020-07-20 | 2022-11-29 | Abbott Laboratories | Digital pass verification systems and methods |
| US11514737B2 (en) | 2020-07-20 | 2022-11-29 | Abbott Laboratories | Digital pass verification systems and methods |
| US10991185B1 (en) | 2020-07-20 | 2021-04-27 | Abbott Laboratories | Digital pass verification systems and methods |
| US10991190B1 (en) | 2020-07-20 | 2021-04-27 | Abbott Laboratories | Digital pass verification systems and methods |
| US11574514B2 (en) | 2020-07-20 | 2023-02-07 | Abbott Laboratories | Digital pass verification systems and methods |
| CN112890805B (zh) * | 2021-01-14 | 2023-06-02 | 四川大学华西医院 | 一种自动寻找伤口并识别伤口状态的仪器 |
| CN112890805A (zh) * | 2021-01-14 | 2021-06-04 | 四川大学华西医院 | 一种自动寻找伤口并识别伤口状态的仪器 |
| CN115645149B (zh) * | 2022-12-14 | 2024-01-23 | 宁夏医科大学总医院 | 一种用于慢性伤口的智能敷料系统 |
| CN115645149A (zh) * | 2022-12-14 | 2023-01-31 | 宁夏医科大学总医院 | 一种用于慢性伤口的智能敷料系统 |
| WO2025099493A1 (fr) * | 2023-11-10 | 2025-05-15 | Linxens Holding | Structure de circuit flexible et agencement à porter intelligent doté d'une telle structure de circuit flexible |
| WO2025099485A1 (fr) * | 2023-11-10 | 2025-05-15 | Linxens Holding | Structure de circuit flexible et agencement de port intelligent doté d'une telle structure de circuit flexible |
| CN118986280A (zh) * | 2024-08-09 | 2024-11-22 | 苏州长润昱华医疗科技有限公司 | 一种基于石墨烯传感器的伤口感染监测预警系统 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013026999A1 (fr) | Système de gestion de plaies | |
| Tang et al. | Multifunctional dressing for wound diagnosis and rehabilitation | |
| Song et al. | Bioresorbable, wireless, and battery-free system for electrotherapy and impedance sensing at wound sites | |
| US20190365571A1 (en) | A dressing system | |
| Almeida et al. | Smart dressings for wound healing: a review | |
| Patel et al. | Wearable electronics for skin wound monitoring and healing | |
| US11369313B2 (en) | Patch-type sensor module | |
| Cheng et al. | Recent progress in intelligent wearable sensors for health monitoring and wound healing based on biofluids | |
| EP4368156A2 (fr) | Système et procédé de surveillance de stomie | |
| EP2451349B1 (fr) | Pansement de lésion avec un capteur d'impédance | |
| US20080262376A1 (en) | Wireless sensor system for monitoring skin condition using the body as communication conduit | |
| US9510781B2 (en) | Dormant to active appurtenances for reporting information regarding wound dressings | |
| EP2836177A1 (fr) | Équipements connexes pour rapporter des informations concernant des pansements pour plaies | |
| Yang et al. | Soft, wireless electronic dressing system for wound analysis and biophysical therapy | |
| CN107049604A (zh) | 智能创可贴 | |
| CN204744627U (zh) | 尿布湿度感测装置及监测系统 | |
| Zhou et al. | A wearable self-charging electroceutical device for bacteria-infected wound healing | |
| CN106983603A (zh) | 智能卫生巾 | |
| Ryu et al. | Materials and device designs for wireless monitoring of temperature and thermal transport properties of wound beds during healing | |
| JP2024532351A (ja) | 慢性創傷の管理および組織再生の加速のための無線閉ループスマートバンデージ | |
| CN107149524A (zh) | 智能卫生棉条 | |
| US20250312591A1 (en) | Electrotherapy system and applications of same | |
| Chopra et al. | Wearable technology based smart dressing for effective wound monitoring–correspondence | |
| TWI697667B (zh) | 尿液電性檢測裝置與方法 | |
| US20230165472A1 (en) | Devices, systems and methods for monitoring physiological characteristics of a patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12775823 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2012775823 Country of ref document: EP |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 12775823 Country of ref document: EP Kind code of ref document: A1 |